Studies of various analogs related to the antipicornavirus agent, 4',5-dihydroxy-3,3',7-trimethoxyflavone (Ro 09-0179), led to the identification of 4'-ethoxy-2'-hydroxy4,6'-dimethoxychalcone (Ro 09-0410), a new and different type of antiviral agent. Ro 09-0410 had a high activity against rhinoviruses but no activity against other picorraviruses. Of 53 rhinovirus serotypes so far tested, 46 were susceptible to Ro 09-0410 in HeLa cell cultures. The concentration of Ro 09-0410 inhibiting 50% of the types of rhinovirus was about 0.03 ,ug/ml, whereas the 50%o cytotoxic concentration was 30 ,Ig/thl. Ro 09-0410 inactivated rhinoviruses in direct dose-, time-, and temperture-dependent fashion. Since infectivity, reduced by exposure to the agent, completely regained the original level by extraction of the agent with chloroform, the inactivation may be associated with the binding of the agent to some specific site of the rhinovirus capsid.
Ro 09-0179 (4',5-dihydroxy-3,3',7-trimethoxyflavone), a potent antipicornavirus agent, was isolated from a Chinese medicinal herb, Agastache Folium (Agastache rugosa Kuntze) (3) . The discovery of this agent led to the synthesis of a series of derivatives and testing of their antiviral activities in tissue culture. Among hundreds of compounds prepared and evaluated, Ro 09-0410 (4'-ethoxy-2'-hydroxy-4,6'-dimethoxychalcone) ( Fig. 1 ) emerged as an agent exclusively active against rhinoviruses.
The mode of action of Ro 09-0410 differed significantly from that of Ro 09-0179. The latter appeared to inhibit the replication of picornavirus at a stage between uncoating and the initiation of RNA synthesis in infected cells (3) . On the other hand, Ro 09-0410 directly inactivated rhinoviruses. Subsequent studies showed that the infectivity of rhinoviruses was reduced by exposure to Ro 09-0410 but was regained completely by the extraction of the agent with chloroform, to which rhinovirus is resistant (1) . While bound to the agent, rhinovirus was inactive. In this report, we describe the results of tissue culture studies on the antirhinovirus activity of Ro 09-0410.
(A part of this study was All rhinoviruses used in this study were purchased from the American Type Culture Collection, Rockville, Md., except type 2 (HGP), which was kindly supplied by R. Kohno, the National Institute of Health of Japan. Viruses were propagated in HeLa and WI-38 cells at 33°C. Poliovirus, echoviruses, coxsackieviruses, mengovirus, vesicular stomatitis virus, respiratory syncytial virus, herpes simplex virus, vacciia virus, and influenza virus used in this study were propagated as described in the accompanying paper (3).
Asy of rhino titer and ePt"mation of MIC5..
The rhinovirus titer was assayed, and the 509o minimal inhibitory concentration (MIC50) was estimated as described in the accompanying paper (3 3 ,g/ml) was inactivated only slightly even at 0.5 pg/ml (Fig. 4) . Virus inactivation was time and temperature dependent ( Fig. 5 and 6 ), rapid at 33°C and relatively insignificant at 4°C.
Ro 09-0410 did not affect all virus particles. More than 1/1,000 of rhinovirus type 2 particles survived even at high doses or with incubation for longer periods. However, all 12 virus clones which survived exposure to this agent at a concentration of 0.5 ,g/ml for 1 h at 33°C showed the same susceptibility to the agent Susceptibility of rhinoviruses to Ro 09-0410 detected by inhibition of viral replication and by direct virus inactivation. To determine whether Ro 09-0410 inhibits viral replication in cell culture through the direct inactivation of rhinovirus, susceptibility to the agent detected by the virus inactivation was compared with that detected by the inhibition of viral replication in cell culture, represented as MIC50 (,ug/ml). In Fig. 7 er, the infectivity of the virus exposed to the agent regained the original level after the extraction of the agent with chloroform. Rhinovirus, while bound to the agent, was inactive. On the other hand, the complex thus formed appeared to be stable. The infectivity of rhinovirus type 2, which was exposed to the agent and isolated by sucrose gradient centrifugation, was not regained at all even after incubation at 33°C for 23 h, although it was regained by chloroform extraction. DISCUSSION The present work showed that Ro 09-0410 is highly and specifically active against rhinoviruses. The activity against 46 of 53 types of rhinoviruses was demonstrable at concentrations as low as 0.003 to 3 ,ug/ml. Ro 09-0410 was completely inactive against other viruses. It also inactivated rhinovirus directly.
The direct inactivation of rhinoviruses by low concentration of Ro 09-0410 suggests that these viruses have a capacity for binding this agent on the capsid not common to other picornaviruses.
The structure of rhinovirus is known to be slightly different from that of other picornaviruses, such as enteroviruses and cardioviruses, and the instability at mildly acidic pH (below 6) is the most common characteristic property of this virus (2, (4) (5) (6) .
Chemotherapeutic indices of Ro 09-0410 in tissue cultures against several types of rhinovirus were greater than 104. In toxicological studies Ro 09-0410 produced no adverse effects when administered to rodents by either the intraperitoneal or oral route at a dose of 1 g/kg daily for 2 weeks (personal observation). Further evaluations should be carried out in humans or nonhuman primates, the only subjects susceptible to infection with rhinoviruses. Pharmacokinetic studies of Ro 09-0410 and its orally active prodrugs are under way in rats and in humans.
